Iodixanol is a contrast agent used during coronary angiography, particularly in patients with renal dysfunction. A medication used in X-ray examinations of blood or lymph vessels.
- Mechanism
- Curator reviewed
Organic iodine compounds attenuate x-rays as they pass through the body, thereby allowing the body structures containing iodine to be delineated in contrast to those structures that do not contain iodine. The degree of opacity produced by these compounds is directly proportional to the total amount (concentration and volume) of the iodinated contrast agent in the path of the x-rays. After intravascular administration, iodixanol makes opaque those internal structures in its path of flow, allowing their visualization until significant hemodilution and elimination occur.
- Primary indication
- Iodixanol is a contrast agent during coronary angiography.Curator reviewed · 9 structured indications
- Formula / weight
- C35H44I6N6O15 · 1550.1819 g/mol (avg)
- First approval
- Canada, 2021 · United States, 2002
- Also known as
- Indixanol
- Brand names
Resolves to
NBQNWMBBSKPBAY-UHFFFAOYSA-NSMILESCC(=O)N(CC(O)CN(C(C)=O)C1=C(I)C(C(=O)NCC(O)CO)=C(I)C(C(=O)NCC(O)CO)=C1I)C1=C(I)C(C(=O)NCC(O)CO)=C(I)C(C(=O)NCC(O)CO)=C1IWhat you can answer from here — as of September 13, 2026
Which other approved drugs treat the same conditions as Iodixanol, and which companies have late-stage candidates in those indications?
Create a free account or log in to explore the full data card.
Create Account